These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20706122)

  • 1. Circulating tumor cells and emerging blood biomarkers in breast cancer.
    Criscitiello C; Sotiriou C; Ignatiadis M
    Curr Opin Oncol; 2010 Nov; 22(6):552-8. PubMed ID: 20706122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
    Mostert B; Sleijfer S; Foekens JA; Gratama JW
    Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating tumor cells in primary and metastatic breast cancer.
    Aurilio G; Sciandivasci A; Munzone E; Sandri MT; Zorzino L; Cassatella MC; Verri E; Rocca MC; Nolè F
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):203-14. PubMed ID: 22316368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery.
    Sandri MT; Zorzino L; Cassatella MC; Bassi F; Luini A; Casadio C; Botteri E; Rotmensz N; Adamoli L; Nolè F
    Ann Surg Oncol; 2010 Jun; 17(6):1539-45. PubMed ID: 20135356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
    Pestrin M; Bessi S; Galardi F; Truglia M; Biggeri A; Biagioni C; Cappadona S; Biganzoli L; Giannini A; Di Leo A
    Breast Cancer Res Treat; 2009 Dec; 118(3):523-30. PubMed ID: 19597704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longtime recirculating tumor cells in breast cancer patients.
    Pachmann K
    Clin Cancer Res; 2005 Aug; 11(15):5657; author reply 5657-8. PubMed ID: 16061886
    [No Abstract]   [Full Text] [Related]  

  • 11. [Circulating stem cells: a comparison of breast cancer and cardiovascular pathology].
    Bershteĭn LM
    Vopr Onkol; 2009; 55(5):528-33. PubMed ID: 20020646
    [No Abstract]   [Full Text] [Related]  

  • 12. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M; Sandri MT
    Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 as marker for the detection of circulating tumor cells.
    Müller V; Pantel K
    Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating tumor cells in patients with breast cancer dormancy.
    Meng S; Tripathy D; Frenkel EP; Shete S; Naftalis EZ; Huth JF; Beitsch PD; Leitch M; Hoover S; Euhus D; Haley B; Morrison L; Fleming TP; Herlyn D; Terstappen LW; Fehm T; Tucker TF; Lane N; Wang J; Uhr JW
    Clin Cancer Res; 2004 Dec; 10(24):8152-62. PubMed ID: 15623589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
    Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E
    Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. By the numbers: does circulating tumor cell enumeration have a role in metastatic breast cancer?
    Liu MC
    J Clin Oncol; 2014 Nov; 32(31):3479-82. PubMed ID: 25245442
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge.
    Vermeulen PB; van Golen KL; Dirix LY
    Cancer; 2010 Jun; 116(11 Suppl):2748-54. PubMed ID: 20503405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
    Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
    Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.